2 unchanged sentences
File/Furnished Herewith
−Removed: BioAtla Director Compensation Policy
+Added: China Clinical Trial Services Agreement, dated April 8, 2022, by and between BioAtla, Inc.
+Added: and Himalaya Therapeutics Limited Company.
Certification of Chief Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
4 unchanged sentences
the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document.
−Removed: The following materials from BioAtla’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2022, formatted in iXBRL (inline eXtensible Business Reporting Language):
+Added: The following materials from BioAtla’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2022, formatted in iXBRL (inline eXtensible Business Reporting Language):
(i) the Condensed Consolidated Balance Sheets, (ii) the Condensed Consolidated Statements of Operations and Comprehensive Loss, (iii) the Condensed Consolidated Statements of Stockholders’
3 unchanged sentences
+ Indicates management contract or compensatory plan.
+Added: * Portions of this exhibit have been redacted in accordance with Item 601(b)(10)(iv) of Regulation S-K.
+Added: Annexes have been omitted pursuant to Item 601(a)(5).
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
+Added: August 9, 2022
Chief Executive Officer
(Principal Executive Officer)
+Added: August 9, 2022
/s/ Richard A.
2 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.